The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 26 | 40.4x | 20.1x | Below average | |
Growth | 58 | 13.1% | 5.6% | Near average | |
Quality | 69 | 63.2% | 7.6% | Above average | |
Safety | 79 | 0.1x | 0.4x | Above average | |
Capital Return | 64 | — | 2.19% | Near average | |
Momentum | 25 | — | — | Below average | |
Sentiment | 40 | — | — | Near average |
IDEXX Laboratories, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy IDEXX Laboratories, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Analysts' outlook for IDXX has seen a notable decline over the past 30 days, with the average price target dropping by 4.7% to reach $747.5. This negative adjustment coincided with new analysts entering the coverage, leading to increased dispersion between a minimum of $640 and a maximum of $800, reflecting uncertainty regarding the stock's current valuation despite the price target remaining above the current trading price.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.